関連する実験動画
Updated: Sep 8, 2025
07:20
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
644
アントロシノール媒介によるATG5のダウンレギュレーションは,レンバチニブ耐性肝細胞がん細胞におけるPERK/ CHOPシグナル伝達を通じて,自己消化に依存した細胞死を誘発し,展開されたタンパク質応答を活性化します
Shiue-Wei Lai1, Yi-Chiao Cheng2, Ming-Shou Hsieh3
1Division of Hematology/Oncology, Department of Internal Medicine, Tri-service General Hospital, National Defense Medical Center, Taipei, Taiwan.
European journal of pharmacology
|September 5, 2025
まとめ
アントロシノールは 薬剤耐性肝癌の治療に 有望です この化合物は,レンバチニブと併用して,細胞死を促進し,展開されたタンパク質応答を活性化し,オートファギーを促進することによって腫瘍の成長を抑制します.
科学分野:
- 腫瘍学
- 分子生物学
- 薬理学について
背景:
- 肝細胞癌 (HCC) は,レンバチニブのような治療に耐性を発症することが多い.
- 新しい治療薬の特定は,薬剤耐性HCCの治療に不可欠です.
- AntrocinolのようなAntrodia cinnamomea誘導体は,その抗がん性について調査されています.
研究 の 目的:
- 薬剤耐性HCCの潜在的な治療法としてAntrocinolを評価する.
- アントロシノールの抗がん作用の基礎となるメカニズムを調査し,オートファジーと展開タンパク質応答 (UPR) に及ぼす影響を含む.
- HCCの臨床前モデルにおけるLenvatinibとAntrocinolの相乗効果を評価する.
主な方法:
- レンバチニブ耐性HCC細胞系 (Huh- 7/ LR, HepG2/ LR) の発生
- 細胞活性の評価,アポトーシス,および自己死に依存する細胞死.
- ウエスタン・ブロットとqRT-PCRを用いたUPR経路マーカーの分析
- オーソトピックHCCマウスモデルを用いたin vivo有効性試験
主要な成果:
- アントロシノールはレンバチニブ耐性HCC細胞の生存能力を低下させ,アポトーシスを誘発した.
- アントロシノールはUPR経路 (BiP/GRP78,PERK,eIF2α,ATF4,CHOP) を活性化し,オートファジーに依存する細胞死を促進した.
- アントロシノールはレンバチニブと相乗効果を示し,腫瘍の成長をインビトロとインビボの両方で抑制した.
- shATG5 感染による自己消化抑制は,アントロシノール誘発の細胞死を廃止した.
結論:
- アントロシノールは,HCCにおけるレンバチニブ耐性を克服する有望な小分子薬剤候補である.
- アントロシノールは,UPR (PERK/ CHOP軸) を活性化させ,オートファジー依存の細胞死を促進することによって,HCCにおける化学反応感受性を高めます.
- オートファギーはHCCの腫瘍抑制メカニズムとして作用し,薬剤耐性症例の治療の可能性を提供します.
関連する概念動画
01:18Autophagic Cell Death
3.5K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K
01:15Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
01:37The Unfolded Protein Response
5.1K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.1K
01:31The Intrinsic Apoptotic Pathway
6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:31Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K